Northern Trust
NYMX

Northern Trust’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Northern Trust’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-371,944
Closed -$826K – 4642
2021
Q1 		$826K Sell
371,944
-28,913
-7% -$76.2K ﹤0.01% 3658
2020
Q4 		$994K Buy
400,857
+1,705
+0.4% +$3.77K ﹤0.01% 3523
2020
Q3 		$982K Sell
399,152
-8,780
-2% -$25.6K ﹤0.01% 3403
2020
Q2 		$1.45M Buy
+407,932
New +$1.29M ﹤0.01% 3202
2019
Q3 		– Sell
-262,351
Closed -$381K – 4306
2019
Q2 		$381K Sell
262,351
-20,431
-7% -$35.7K ﹤0.01% 3632
2019
Q1 		$557K Buy
282,782
+5,225
+2% +$11.1K ﹤0.01% 3520
2018
Q4 		$363K Buy
277,557
+6,026
+2% +$11K ﹤0.01% 3628
2018
Q3 		$668K Sell
271,531
-1,294
-0.5% -$3.82K ﹤0.01% 3575
2018
Q2 		$916K Buy
272,825
+21,828
+9% +$83.9K ﹤0.01% 3475
2018
Q1 		$1.06M Buy
250,997
+5,177
+2% +$17.9K ﹤0.01% 3362
2017
Q4 		$812K Sell
245,820
-5,790
-2% -$21.1K ﹤0.01% 3456
2017
Q3 		$962K Buy
251,610
+206,309
+455% +$782K ﹤0.01% 3445
2017
Q2 		$199K Buy
+45,301
New +$186K ﹤0.01% 3800
2014
Q3 		– Sell
-27,050
Closed -$134K – 4368
2014
Q2 		$134K Buy
+27,050
New +$139K ﹤0.01% 3955

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Northern Trust's NYMX Position: Q2 2021 in Review

Northern Trust sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 371,944 shares — an estimated $826K sold.

Northern Trust first reported a position in NYMX in Q2 2014 and held it in 14 quarters. The position peaked at $1.45M in Q2 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Northern Trust reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
  • Northern Trust sold 371,944 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $826K.
  • Northern Trust first reported a position in Nymox Pharmaceutical Corp in Q2 2014 and held it in 14 quarters.
  • Northern Trust's Nymox Pharmaceutical Corp position peaked at $1.45M in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.